A new strategy toward improving immunoprotection in cell therapy for diabetes mellitus: Long-functioning PEGylated islets in vivo

Tissue Engineering

Volumn 12, Issue 3, 2006, Pages 615-623

  Lee, Dong Yun ^a   Park, Sang Jin ^b   Nam, Jong Hee ^c   Byun, Youngro ^a  

^a Seoul National University   (South Korea)

^b Gwangju Institute of Science and Technology (GIST)   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; CELL CULTURE; DISEASES; POLYETHYLENE GLYCOLS; SURFACE TREATMENT; TRANSPLANTATION (SURGICAL);

CELL THERAPY; DIABETES MELLITUS; ISLET TRANSPLANTATION; PEGYLATED ISLETS;

IMMUNOLOGY;

CYCLOSPORIN A; INSULIN; MACROGOL;

ADOPTIVE IMMUNOTHERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DIABETES MELLITUS; GRAFT SURVIVAL; HOST; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IN VIVO STUDY; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT; SURFACE PROPERTY; SURVIVAL TIME;

ANIMALIA;

EID: 33646351744     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.12.615     Document Type: Article

References (28)

1. Markmann, J.F., Deng, S., Huang, X., Desai, N.M., Velidedeoglu, E.H., Lui, C., Frank, A., Markmann, E., Palanjian, M., Brayman, K., Wolf, B., Bell, E., Vitamaniuk, M., Doliba, N., Matschinsky, F., Barker, C.F., and Naji, A. Insulin independence following isolated islet transplantation and single islet infusions. Ann. Surg. 237, 741, 2003.
2. Shapiro, A.M., Lakey, J.R., Ryan, E.A., Korbutt, G.S., Toth, E., Warnock, G.L., Kneteman, N.M., and Rajotte, R.V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343, 230, 2000.
3. Platz, K.P., Mueller, A.R., Blumhardt, G., Bachmann, S., Bechstein, W.O., Kahl, A., and Neuhaus, P. Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation 58, 170, 1994.
4. Taler, S.J., Textor, S.C., Canzanello, V.J., Schwartz, L., Porayko, M., Wiesner, R.H., and Krom, R.A. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine. Transplantation 62, 1588, 1996.
5. Ayres, R.C., Dousset, B., Wixon, S., Buckels, J.A., McMaster, P., and Mayer, A.D. Peripheral neurotoxicity with tacrolimus. Lancet 343, 862, 1994.
6. Mach-Pascual, S., Samii, K., and Beris, P. Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy. Am. J. Hematol. 52, 310, 1996.
7. Ryan, E.A., Lakey, J.R., Rajotte, R.V., Korbutt, G.S., Kin, T., Imes, S., Rabinovitch, A., Elliott, J.F., Bigam, D., Kneteman, N.M., Warnock, G.L., Larsen, I., and Shapiro, A.M. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50, 710, 2001.
8. Lanza, R.P., Hayes, J.L., and Chick, W.L. Encapsulated cell technology. Nat. Biotechnol. 14, 1107, 1996.
9. de Vos, P., Hamel, A.F., and Tatarkiewicz, K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 45, 159, 2002.
10. Lanza, R.P., Kuhtreiber, W.M., Ecker, D., Staruk, J.E., and Chick, W.L. Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. Transplantation 59, 1377, 1995.
11. Panza, J.L., Wagner, W.R., Rilo, H.L.R., Rao, R.H., Beckman, E.J., and Russell, A.J. Treatment of rat pancreatic islets with reactive PEG. Biomaterials 21, 1155, 2000.
12. Lee, D.Y., Yang, K., Lee, S., Chae, S.Y., Kim, K.-W., Lee, M.K., Han, D.-J., and Byun, Y. Optimization of monomethoxy-polyethylene glycol grafting on the pancreatic islet capsules. J. Biomed. Mater. Res. 62, 372, 2002.
13. Lee, D.Y., Jang, J.Y., Park, S.J., and Byun, Y. Immune reactions of lymphocytes and macrophages against PEG-grafted pancreatic islets. Biomaterials 25, 3663, 2004.
14. Lee, D.Y., Nam, J.H., and Byun, Y. Effect of polyethylene glycol grafted onto islet capsules on prevention of splenocytes and cytokine attacks. J. Biomater. Sci. Polym. Ed. 15, 753, 2004.
15. Contreras, J.L., Xie, D., Mays, J., Smyth, C.A., Eckstein, C., Rahemtulla, F.G., Young, C.J., Thompson, J.A., Bilbao, G., Curiel, D.T., and Eckhoff, D.E. A novel approach to xenotransplantation combining surface engineering and genetic modification of isolated adult porcine islets. Surgery 136, 537, 2004.
16. Xie, D., Smyth, C.A., Eckstein, C., Bilbao, G., Mays, J., Eckhoff, D.E., and Contreras, J.L. Cytoprotection of PEG-modified adult porcine pancreatic islets for improved xenotransplantation. Biomaterials 26, 403, 2005.
17. Scott, M.D., Murad, K.L., Koumpouras, F., Talbot, M., and Eaton, J.W. Chemical camouflage of antigenic determinants: stealth erythrocytes. Proc. Natl. Acad. Sci. USA 94, 7566, 1997.
18. Murad, K.L., Mahany, K.L., Brugnara, C., Kuypers, F.A., Eaton, J.W., and Scott, M.D. Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol). Blood 93, 2121, 1999.
19. Murad, K.L., Gosselin, E.J., Eaton, J.W., and Scott, M.D. Stealth cells: Prevention of major histocompatibility complex class II-mediated T-cell activation by cell surface modification. Blood 94, 2135, 1999.
20. Amiji, M., and Park, K. Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and heparin for reduced thrombogenicity. In: Cooper, S.L., Bamford, C.H., and Tsuruta, T., eds., Polymer Biomaterials in Solution, As Interfaces and As Solids. Utrecht: VSP, 1995, pp. 535-552.
21. Hoofman, G., Herman, S., and Schacht, E. Poly(ethylene glycol) with reactive end groups: I. Modification of proteins. J. Bioact. Compat. Pol. 10, 145, 1995.
22. Bank, H.L. Assessment of islet cell viability using fluorescent dyes. Diabetologia 30, 812, 1987.
23. Sayegh, M.H., Watschinger, B., and Carpenter, C.B. Mechanisms of T cell recognition of alloantigen. The role of peptides. Transplantation 57, 1295, 1994.
24. Lee, R.S., Grusby, M.J., Glimcher, L.H., Winn, H.J., and Auchincloss, H. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J. Exp. Med. 179, 865, 1994.
25. Babensee, J.E., Anderson, J.M., McIntire, L.V., and Mikos, A.G. Host response to tissue engineered devices. Adv. Drug Deliv. Rev. 33, 111, 1998.
26. Palmer, J.P., Helqvist, S., Spinas, G.A., Molvig, J., Mandrup-Poulsen, T., Andersen, H.U., and Nerup, J. Interaction of β-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes 38, 1211, 1989.
27. Ling, Z., In't Veld, P.A., and Pipeleers, D.G. Interaction of interleukin-1 with islet β-cells. Diabetes 42, 56, 1993.
28. Campbell, I.L., Iscaro, A., and Harrison, L.C. IFN-γ and tumor necrosis factor-α. Cytotoxicity to murine islets of Langerhans. J. Immunol. 141, 2325, 1988.